i8-k.htm

 
UNITED STATES
 
 
SECURITIES AND EXCHANGE COMMISSION
 
 
WASHINGTON, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT PURSUANT
 
 
TO SECTION 13 OR 15(D) OF THE
 
 
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of report (Date of earliest event reported): November 8, 2011
 
INSMED INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
       
Virginia
(State or Other Jurisdiction of Incorporation)
       
0-30739
54-1972729
(Commission File Number)
(IRS Employer Identification No.)
       
11 Deer Park Drive, Monmouth Junction, NJ
08852
(Address of Principal Executive Offices)
(Zip Code)
       
(732) 438-9434
(Registrant’s Telephone Number, Including Area Code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
 

 
 
 
INFORMATION TO BE INCLUDED IN THE REPORT
 
 
Section 2—Financial Information
 
Item 2.02.
Results of Operations and Financial Condition.
 
On November 8, 2011, Insmed Incorporated issued a press release regarding its financial results for the three and nine months ended September 30, 2011. A copy of the press release is attached hereto as Exhibit 99.1.
 
 
The information contained herein, including the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
 
Item 9.01. Financial Statements and Exhibits.
 
 
(d) Exhibits
 
 
Exhibit No. Description
 
99.1
Press Release issued by Insmed Incorporated on November 8, 2011.
 

 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Insmed Incorporated
   
   
Date: November 8, 2011
 
 
By: /s/ Kevin P. Tully
 
Name: Kevin P. Tully C.G.A.,
 
Title: Executive Vice President & Chief Financial Officer
   
 
 

 
 
EXHIBIT INDEX
 
 
Exhibit No. Description
 
99.1
Press Release issued by Insmed Incorporated on November 8, 2011